Ron tyrosine kinase receptor synergises with EGFR to confer adverse features in head and neck squamous cell carcinoma

BACKGROUND: Although EGFR inhibitors have shown some success in the treatment of head and neck squamous cell carcinomas (HNSCCs), the results are not dramatic. Additional molecular targets are urgently needed. We previously showed that the loss of Ron receptor activity significantly slowed squamous...

Descripción completa

Detalles Bibliográficos
Autores principales: Keller, J, Nimnual, A S, Shroyer, K R, Joy, C, Ischenko, I, Chandler, C S, Dong, L M, Hayman, M J, Chan, E L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721396/
https://www.ncbi.nlm.nih.gov/pubmed/23799848
http://dx.doi.org/10.1038/bjc.2013.321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721396/
https://www.ncbi.nlm.nih.gov/pubmed/23799848
http://dx.doi.org/10.1038/bjc.2013.321

Ejemplares similares